Cellectricon and BioFocus DPI Advance Ion Channel Drug Discovery

Cellectricon has announced its collaboration with BioFocus DPI, a contract research organization with expertise in ion channel screening. The latter will utilize the former’s DynaflowHT, a fully Automated Patch Clamp (APC) system, to further increase the latter’s electrophysiology-based screening capacity, particularly for fast ligand-gated ion channels.

“This collaboration gives us the opportunity to increase the throughput we provide for customers as well as the number of ion channel subtypes we can screen in an electrophysiology-based format,” said Dr Kate Hilyard, VP Biological Sciences, BioFocus DPI.